Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 209 (2), 598-600
- https://doi.org/10.1016/j.atherosclerosis.2009.10.021
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Plasma ADMA Predicts Restenosis of Arteriovenous FistulaJournal of the American Society of Nephrology, 2009
- High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated MechanismsDiabetes, 2007
- Local Activation of Interleukin 6 Signaling Is Associated With Arteriovenous Fistula Stenosis in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activityKidney International, 2005
- Vascular Access in Hemodialysis: Issues, Management, and Emerging ConceptsCardiology Clinics, 2005
- Dysfunctional Autogenous Hemodialysis Fistulas: Outcomes after Angioplasty—Are There Clinical Predictors of Patency?Radiology, 2004
- Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis patientsKidney International, 2003
- Hemodialysis vascular access survival: Upper-arm native arteriovenous fistulaAmerican Journal of Kidney Diseases, 2002
- Hemodialysis access failure: A call to actionKidney International, 1998
- Potential mechanisms promoting restenosis in diabetic patientsJournal of the American College of Cardiology, 1996